학술논문
52MO A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S563-S563
Subject
Language
ISSN
0923-7534